14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AQST
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for Aquestive Therapeutics Inc.
(Updated on Apr 16, 2024)

Hold candidate since Apr 15, 2024 Loss -2.28% PDF

The Aquestive Therapeutics Inc. stock price fell by -2.28% on the last day (Tuesday, 16th Apr 2024) from $3.94 to $3.85. During the last trading day the stock fluctuated 4.57% from a day low at $3.72 to a day high of $3.89. The price has fallen in 6 of the last 10 days and is down by -7% for this period. Volume has increased on the last day by 542 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $7.25 million.

Given the current short-term trend, the stock is expected to rise 58.72% during the next 3 months and, with a 90% probability hold a price between $6.11 and $11.05 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

AQST Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aquestive Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.00 and $4.43. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 15, 2024, and so far it has fallen -36.78%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Aquestive Therapeutics Inc. stock

Aquestive Therapeutics Inc. finds support from accumulated volume at $3.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.170 between high and low, or 4.57%. For the last week, the stock has had daily average volatility of 6.50%.

Our recommended stop-loss: $3.70 (-3.90%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 21 days ago.)

Trading Expectations (AQST) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Aquestive Therapeutics Inc. to open at $3.82, and during the day (based on 14 day Average True Range), to move between $3.48 and $4.22, which gives a possible trading interval of +/-$0.366 (+/-9.52%) up or down from last closing price. If Aquestive Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 19.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.67 (4.68%) than the resistance at $4.18 (8.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aquestive Therapeutics Inc. stock A Buy?

Aquestive Therapeutics Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.357 Hold/Accumulate Unchanged

Predicted Opening Price for Aquestive Therapeutics Inc. of Wednesday, April 17, 2024

Fair opening price April 17, 2024 Current price
$3.82 ( 0.779%) $3.85

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AQST

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.99 3.64 %
R2 3.93 1.95 %
R1 3.88 0.91 %
Current price: 3.85
Support S1 3.76 -2.47 %
S2 3.71 -3.51 %
S3 3.65 -5.19 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.51 17.01 %
R2 4.38 13.77 %
R1 4.18 8.57 %
Current price 3.85
Support S1 3.67 -4.68%
S2 3.65 -5.19%
S3 3.20 -16.88%

FAQ

What is the symbol for Aquestive Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Aquestive Therapeutics Inc. is AQST and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aquestive Therapeutics Inc. Stock?
Aquestive Therapeutics Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Aquestive Therapeutics Inc. Stock?
Aquestive Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aquestive Therapeutics Inc. Stock.

What's the current price of Aquestive Therapeutics Inc. Stock?
As of the end of day on the 2024-04-16, the price of an Aquestive Therapeutics Inc. (AQST) share was $3.85.

What is the 52-week high and low for Aquestive Therapeutics Inc. Stock?
The 52-week high for Aquestive Therapeutics Inc. Stock is $6.23 and the 52-week low is $1.16.

What is the market capitalization of Aquestive Therapeutics Inc. Stock?
As of the 2024-04-16, the market capitalization of Aquestive Therapeutics Inc. is 354.474M.

When is the next earnings date for Aquestive Therapeutics Inc.?
The upcoming earnings date for Aquestive Therapeutics Inc. is May 07, 2024.
Click to get the best stock tips daily for free!

About Aquestive Therapeutics Inc.

Aquestive Therapeutics. Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral ... AQST Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT